All Stories

  1. The genital tract microbiome: bridging the gap between hype and clinical reality
  2. Genital tract microbiota composition profiles and use of prebiotics and probiotics in gynaecological cancer prevention: review of the current evidence, the European Society of Gynaecological Oncology prevention committee statement
  3. Chlamydial and Gonococcal Genital Infections: A Narrative Review
  4. Low genitourinary tract risks in women living with the human immunodeficiency virus
  5. The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) consensus st...
  6. Vulvar High-Grade Squamous Intraepithelial Lesion and the Risk of Recurrence and Progression to Cancer
  7. Scoping review of cytolytic vaginosis literature
  8. International Society for the Study of Vulvovaginal Disease Recommendations for the Diagnosis and Treatment of Vaginitis
  9. Chronic Hypertrophic Herpes Simplex Infection: A 13-Year Delay
  10. Therapeutic Options for Chlamydia trachomatis Infection: Present and Future
  11. Reply to De Giorgi et al. Comment on “Kesić et al. Early Diagnostics of Vulvar Intraepithelial Neoplasia. Cancers 2022, 14, 1822”
  12. Efficacy of Hormonal and Nonhormonal Approaches to Vaginal Atrophy and Sexual Dysfunctions in Postmenopausal Women: A Systematic Review
  13. Vulvar Paget's disease: outcomes of 51 patients treated with imiquimod cream
  14. Vaginal Leptothrix: An Innocent Bystander?
  15. Changes in the Vaginal Microbiota of Women With Secondary Localized Provoked Vulvodynia
  16. The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) consensus sta...
  17. Early Diagnostics of Vulvar Intraepithelial Neoplasia
  18. Wet Mount Microscopy of the Vaginal Milieu Does Not Predict the Outcome of Fertility Treatments
  19. COVID-19 related acute genital ulcer: a case report
  20. The Vaginal Microbiome: I. Research Development, Lexicon, Defining “Normal” and the Dynamics Throughout Women's Lives
  21. The Vaginal Microbiome: II. Vaginal Dysbiotic Conditions
  22. The Vaginal Microbiome: III. The Vaginal Microbiome in Various Urogenital Disorders
  23. The Vaginal Microbiome: IV. The Role of Vaginal Microbiome in Reproduction and in Gynecologic Cancers
  24. The Vaginal Microbiome: V. Therapeutic Modalities of Vaginal Microbiome Engineering and Research Challenges
  25. Vulvar High-Grade Squamous Intraepithelial Lesions and Cancer as a Risk Factor for Anal Cancer: A Review
  26. Use of Moisturizers and Lubricants for Vulvovaginal Atrophy
  27. Hormonal Approach for Postmenopausal Vulvovaginal Atrophy
  28. Genitourinary Syndrome of Menopause: Epidemiology, Physiopathology, Clinical Manifestation and Diagnostic
  29. G-spot: Fact or Fiction?: A Systematic Review
  30. Superficially Invasive Vulvar Squamous Cell Carcinoma: A 37-Year-Long Experience of a Tertiary Referral Center
  31. Diagnosis of bacterial vaginosis: Clinical or microscopic? A cross‐sectional study
  32. Cytology Is Not Reliable to Evaluate Cervical Disease Regression
  33. Management of postmenopausal vulvovaginal atrophy: recommendations of the International Society for the Study of Vulvovaginal Disease
  34. Clinical manifestations and evaluation of postmenopausal vulvovaginal atrophy
  35. For Anal Cancer, Not All Women Are Equal
  36. Clinical validation of a new molecular test (Seegene Allplex™ Vaginitis) for the diagnosis of vaginitis: a cross‐sectional study
  37. Clarification about vulvar cancer precursor lesions
  38. The International Society for the Study of Vulvovaginal Disease Vaginal Wet Mount Microscopy Guidelines: How to Perform, Applications, and Interpretation
  39. Knowledge of Vulvar Anatomy and Self-examination in a Sample of Italian Women
  40. Letter to the editor: “Do variations in labial anatomy have an effect on recurrent urinary tract infection?”
  41. Erosive Vulvar Lichen Planus and Risk of Vulvar Neoplasia
  42. Prognostic factors for recurrence and survival in uncommon variants of vulvar cancer
  43. Cross-Protective IgG and IgA Antibodies against Oncogenic and Non-Oncogenic HPV Genotypes
  44. Impact of a High Coverage Vaccination Rate on Human Papillomavirus Infection Prevalence in Young Women: A Cross-sectional Study
  45. Better studies needed on LASER use in urinary incontinence
  46. Prognostic factors in patients with vulvar cancer: the VULCAN study
  47. Editorial Comment: The clinical role of LASER for vulvar and vaginal treatments in gynecology and female urology: An ICS/ISSVD best practice consensus document
  48. Better triage tests needed for HPV‐positive women
  49. Adult Vulvar Lichen Sclerosus: Can Experts Agree on the Assessment of Disease Severity?
  50. Corrigendum
  51. The International Classification of Diseases, 11th Revision: A Step-Back for Women With Vulvodynia?
  52. Diagnosis of vaginitis: time to improve and move on
  53. Response letter to comments related to “The clinical role of LASER for vulvar and vaginal treatments in gynecology and female urology: An ICS/ISSVD best practice consensus document”
  54. Systematic review and meta-analysis of the effects of treatment modalities for vestibulodynia in women
  55. Vulvodynia: a neglected chronic pain diagnosis
  56. Academic cosmetic gynaecology and energy-based therapies: ambiguities, explorations, and FDA advisories
  57. Descriptors of Vulvodynia: A Multisocietal Definition Consensus (International Society for the Study of Vulvovaginal Disease, the International Society for the Study of Women Sexual Health, and the International Pelvic Pain Society)
  58. Impact of the Sampling Site in the Result of Wet Mount Microscopy
  59. The Clinical Role of LASER for Vulvar and Vaginal Treatments in Gynecology and Female Urology: An ICS/ISSVD Best Practice Consensus Document
  60. The clinical role of LASER for vulvar and vaginal treatments in gynecology and female urology: An ICS/ISSVD best practice consensus document
  61. The energy based devices for vaginal “rejuvenation,” urinary incontinence, vaginal cosmetic procedures, and other vulvo‐vaginal disorders: An international multidisciplinary expert panel opinion
  62. Immediate Loop Electrode Excisional Procedure for High-Grade Cervical Cytology: One Size Fits All?
  63. Vulvodynia: A disease commonly hidden in plain sight
  64. International Society for the Study of Vulvovaginal Disease Recommendations Regarding Female Cosmetic Genital Surgery
  65. To the Editor:
  66. Bioengineering Organs for Blood Detoxification
  67. The ReCiDiF method to treat recurrent vulvovaginal candidosis: A friend with benefits
  68. Diagnosis and management of vulvodynia in postmenopausal women
  69. Aerobic vaginitis: no longer a stranger
  70. Clinical Validation of a Test for the Diagnosis of Vaginitis: Correction
  71. Clinical Validation of a Test for the Diagnosis of Vaginitis
  72. Lichen sclerosus in women: a review
  73. Survey on Aesthetic Vulvovaginal Procedures: What do Portuguese Doctors and Medical Students Think?
  74. Women without vulvodynia can have a positive ‘Q-tip test’: a cross sectional study
  75. P-04-003 Prevalence of Sexually Transmitted Diseases Among Women in Principe Island
  76. Deconstructing the genitourinary syndrome of menopause
  77. Genital Tract Infections in an Isolated Community: 100 Women of the Príncipe Island
  78. Is it possible to prevent recurrent vulvovaginitis? The role of Lactobacillus plantarum I1001 (CECT7504)
  79. Is the DSM-V Leading to the Nondiagnosis of Vulvodynia?
  80. Lipschütz ulcers: should we rethink this? An analysis of 33 cases
  81. Bacterial vaginosis and inflammatory response showed association with severity of cervical neoplasia in HPV-positive women
  82. Bacterial vaginosis, aerobic vaginitis, vaginal inflammation and major Pap smear abnormalities
  83. The “Genitourinary Syndrome of Menopause”
  84. Emphysematous Vaginitis
  85. What Differentiates Symptomatic from Asymptomatic Women with Lichen Sclerosus?
  86. Prevalence of vulvodynia and risk factors for the condition in Portugal
  87. Ovarian Leydig cell tumor in a post-menopausal patient with severe hyperandrogenism
  88. Mycoplasma pneumoniae
  89. Lichen Sclerosus in Breast Cancer Survivor
  90. Ovarian intratumoral 21-hydroxylase deficiency in a postmenopausal hirsute woman
  91. Sclerosing stromal tumour of the ovary associated with Meigs' syndrome and elevated CA125
  92. Case report: intra-partum utero-ovarian vessels rupture
  93. Use of extensible internal device in the femur of young dogs
  94. L-band land mobile satellite (LMS) amplitude and multipath phase modeling in urban areas
  95. Mobile and Base Station Diversity Simulation Experiments in a Mobile Communications Course